DUBLIN, Calif., Aug. 2 /PRNewswire-FirstCall/ -- SuperGen Inc., (Nasdaq: SUPG - News), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today reported financial results for the second quarter and six months ended June 30, 2007.
